Recovering Zimbabwe Offers Growth Opportunities for Pharmaceutical Companies, States Frost & Sullivan

Recovery from a decade-long economic contraction has been the main factor behind the growth experienced in Zimbabwe's pharmaceutical sector in the last two years. A new coalition government and subsequent macro-economic stabilisation have brought renewed optimism and spurred demand in healthcare markets. This is driving the uptake of drugs -- a trend that is expected to remain robust in the future with the increasing availability of low-cost generic drugs.